US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

 
• By Sue Sutter
Hearing
The FDA is holding a listening session on several aspects of the adcomm process. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers